154 related articles for article (PubMed ID: 30776567)
1. Role of esterase mediated hydrolysis of simvastatin in human and rat blood and its impact on pharmacokinetic profiles of simvastatin and its active metabolite in rat.
Li Z; Zhang J; Zhang Y; Zuo Z
J Pharm Biomed Anal; 2019 May; 168():13-22. PubMed ID: 30776567
[TBL] [Abstract][Full Text] [Related]
2. Esterase inhibition attribute of grapefruit juice leading to a new drug interaction.
Li P; Callery PS; Gan LS; Balani SK
Drug Metab Dispos; 2007 Jul; 35(7):1023-31. PubMed ID: 17392396
[TBL] [Abstract][Full Text] [Related]
3. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.
Li P; Callery PS; Gan LS; Balani SK
Drug Metab Dispos; 2007 Jul; 35(7):1203-8. PubMed ID: 17452418
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of orally administered simvastatin in turkeys.
Jasiecka A; Grabowski T; Maślanka T; Ziółkowski H; Jaroszewski JJ
Pol J Vet Sci; 2013; 16(2):377-9. PubMed ID: 23971207
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of curcumin diethyl disuccinate and its active metabolite curcumin in rat plasma by LC-MS/MS: Application of esterase inhibitors in the stabilization of an ester-containing prodrug.
Ratnatilaka Na Bhuket P; Niwattisaiwong N; Limpikirati P; Khemawoot P; Towiwat P; Ongpipattanakul B; Rojsitthisak P
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():301-310. PubMed ID: 27595650
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension.
Watanabe H; Kosuge K; Nishio S; Yamada H; Uchida S; Satoh H; Hayashi H; Ishizaki T; Ohashi K
Life Sci; 2004 Dec; 76(3):281-92. PubMed ID: 15531380
[TBL] [Abstract][Full Text] [Related]
7. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Oct; 68(4):384-90. PubMed ID: 11061578
[TBL] [Abstract][Full Text] [Related]
8. Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats.
Li Y; Wu Y; Li YJ; Meng L; Ding CY; Dong ZJ
Molecules; 2019 Apr; 24(9):. PubMed ID: 31035343
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
Neuvonen PJ; Kantola T; Kivistö KT
Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of simvastatin lactone and its active metabolite simvastatin hydroxy acid in healthy Chinese male and female volunteers.
Yang W; Xu H; Song Y; Wang X; Ren X; Zhao D; Cai Y; Zhang S; Huang J; Zhang LR; Zhang T; Zuo M
Int J Clin Pharmacol Ther; 2014 Feb; 52(2):151-8. PubMed ID: 24290412
[TBL] [Abstract][Full Text] [Related]
11. Differences between lovastatin and simvastatin hydrolysis in healthy male and female volunteers:gut hydrolysis of lovastatin is twice that of simvastatin.
Vree TB; Dammers E; Ulc I; Horkovics-Kovats S; Ryska M; Merkx I
ScientificWorldJournal; 2003 Dec; 3():1332-43. PubMed ID: 14755114
[TBL] [Abstract][Full Text] [Related]
12. Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3.
Teiber JF; Draganov DI; La Du BN
Biochem Pharmacol; 2003 Sep; 66(6):887-96. PubMed ID: 12963475
[TBL] [Abstract][Full Text] [Related]
13. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors.
Lilja JJ; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1998 Nov; 64(5):477-83. PubMed ID: 9834039
[TBL] [Abstract][Full Text] [Related]
14. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Pasanen MK; Neuvonen M; Neuvonen PJ; Niemi M
Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
[TBL] [Abstract][Full Text] [Related]
15. Esterase phenotyping in human liver in vitro: specificity of carboxylesterase inhibitors.
Umehara K; Zollinger M; Kigondu E; Witschi M; Juif C; Huth F; Schiller H; Chibale K; Camenisch G
Xenobiotica; 2016 Oct; 46(10):862-7. PubMed ID: 26887925
[TBL] [Abstract][Full Text] [Related]
16. In vitro stability and metabolism of O2', O3', O5'-tri-acetyl-N6-(3-hydroxylaniline) adenosine in rat, dog and human plasma: chemical hydrolysis and role of plasma esterases.
Liu Y; He J; Abliz Z; Zhu H
Xenobiotica; 2011 Jul; 41(7):549-60. PubMed ID: 21486191
[TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic drug-drug interaction model of simvastatin and verapamil in humans.
Methaneethorn J; Chamnansua M; Kaewdang N; Lohitnavy M
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5711-4. PubMed ID: 25571292
[TBL] [Abstract][Full Text] [Related]
18. Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
Devineni D; Manitpisitkul P; Murphy J; Skee D; Wajs E; Mamidi RN; Tian H; Vandebosch A; Wang SS; Verhaeghe T; Stieltjes H; Usiskin K
Clin Pharmacol Drug Dev; 2015; 4(3):226-36. PubMed ID: 27140803
[TBL] [Abstract][Full Text] [Related]
19. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
Yang SH; Choi JS; Choi DH
Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetic characters of simvastatin after co-administration with Shexiang Baoxin Pill in healthy volunteers' plasma.
Tao J; Jiang P; Peng C; Li M; Liu R; Zhang W
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():162-167. PubMed ID: 26830535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
